iRegene

Overview

AI and chemically induced cell drug research and development.

USD estimates from the source record

Listed 7 funding records. Latest funding: $37M (C+), Jul 2, 2026.

Annual trendUnit: USD estimate

4 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors
Aug 18, 2026	金额未知	Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership), Shanghai Dingtaixing Technology Development Co., Ltd., Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership), Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership), Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership)
Jul 14, 2026	金额未披露	Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership)
Jul 2, 2026	$37M	Chengdu Ke Venture Capital, Dingtaixing, Hongyi Capital, Xi Venture Capital, Xinjiye, Yuanxihaihe (Tianjin) Biotechnology Pharmaceutical Industry Fund Partnership (Limited Partnership), Zhongxinjian Investment Ben
Apr 27, 2026	$30M	Xingze Capital
Mar 30, 2026	金额未知	Beijiguang Venture Capital, Guanzi Venture Capital, Hehui Biotechnology
Mar 19, 2026	金额未知	Xiangfeng Investment
Sep 4, 2025	$14M	Beijiguang Venture Capital, Chuangjing Capital, Jinshajianglianhe Capital

USD estimates from the source record

Listed 7 valuation records.

Annual trendUnit: USD estimate

No chartable valuation estimates yet.

7 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors
Aug 18, 2026	—	Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership), Shanghai Dingtaixing Technology Development Co., Ltd., Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership), Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership), Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership)
Jul 14, 2026	—	Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership)
Jul 2, 2026	—	Chengdu Ke Venture Capital, Dingtaixing, Hongyi Capital, Xi Venture Capital, Xinjiye, Yuanxihaihe (Tianjin) Biotechnology Pharmaceutical Industry Fund Partnership (Limited Partnership), Zhongxinjian Investment Ben
Apr 27, 2026	—	Xingze Capital
Mar 30, 2026	—	Beijiguang Venture Capital, Guanzi Venture Capital, Hehui Biotechnology
Mar 19, 2026	—	Xiangfeng Investment
Sep 4, 2025	—	Beijiguang Venture Capital, Chuangjing Capital, Jinshajianglianhe Capital

USD estimates from the source record

No revenue records are listed yet.

Annual trendUnit: USD estimate

No chartable revenue estimates yet.

No revenue rows to list.

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

AI 与化学诱导细胞药物研发